EQUINOX NEPREMICNINE d.d. Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	107	101	94	90	-
Market Cap Growth	9.28%	7.44%	4.88%	-	-
Enterprise Value	115	109	99	96	-
Last Close Price	60.00	56.50	50.94	47.14	-
PE Ratio	74.71	94.50	108.24	125.98	-
PS Ratio	11.54	11.66	12.08	12.21	-
PB Ratio	2.79	2.66	2.36	2.17	-
P/OCF Ratio	-	15.90	16.49	10.82	-
EV/Sales Ratio	12.37	12.59	12.71	13.06	-
EV/EBITDA Ratio	23.54	25.71	23.97	19.93	-
EV/EBIT Ratio	126.99	348.46	269.49	68.35	-
Debt / Equity Ratio	0.21	0.22	0.22	0.35	0.35
Debt / EBITDA Ratio	1.62	1.93	2.15	3.03	3.60
Asset Turnover	0.17	0.17	0.14	0.13	-
Quick Ratio	0.81	0.98	3.15	1.78	5.39
Current Ratio	1.03	0.98	3.15	1.78	5.65
Return on Equity (ROE)	3.64%	2.75%	2.14%	1.75%	-
Return on Assets (ROA)	1.06%	0.37%	0.40%	1.52%	-
Return on Capital (ROIC)	1.19%	0.41%	0.44%	1.60%	-
Earnings Yield	1.34%	1.06%	0.92%	0.79%	-
Dividend Yield	2.82%	-	3.32%	3.03%	-
Payout Ratio	-	282.82%	295.15%	-	-
Buyback Yield / Dilution	-	1.55%	-1.73%	-	-
Total Shareholder Return	2.82%	1.55%	1.59%	3.03%	-

Updated Feb 10, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.